Product NDC: | 63868-008 |
Proprietary Name: | Lansoprazole |
Non Proprietary Name: | Lansoprazole |
Active Ingredient(s): | 15 mg/1 & nbsp; Lansoprazole |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE, DELAYED RELEASE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 63868-008 |
Labeler Name: | QUALITY CHOICE (Chain Drug Marketing Association) |
Product Type: | HUMAN OTC DRUG |
FDA Application Number: | ANDA202727 |
Marketing Category: | ANDA |
Start Marketing Date: | 20130430 |
Package NDC: | 63868-008-42 |
Package Description: | 3 BOTTLE in 1 BOX (63868-008-42) > 14 CAPSULE, DELAYED RELEASE in 1 BOTTLE |
NDC Code | 63868-008-42 |
Proprietary Name | Lansoprazole |
Package Description | 3 BOTTLE in 1 BOX (63868-008-42) > 14 CAPSULE, DELAYED RELEASE in 1 BOTTLE |
Product NDC | 63868-008 |
Product Type Name | HUMAN OTC DRUG |
Non Proprietary Name | Lansoprazole |
Dosage Form Name | CAPSULE, DELAYED RELEASE |
Route Name | ORAL |
Start Marketing Date | 20130430 |
Marketing Category Name | ANDA |
Labeler Name | QUALITY CHOICE (Chain Drug Marketing Association) |
Substance Name | LANSOPRAZOLE |
Strength Number | 15 |
Strength Unit | mg/1 |
Pharmaceutical Classes |